| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 36 | 2019 | 837 | 2.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 32 | 2019 | 1523 | 2.420 |
Why?
|
| Macaca fascicularis | 64 | 2019 | 549 | 2.240 |
Why?
|
| Whole-Body Irradiation | 6 | 2019 | 59 | 1.970 |
Why?
|
| Bone Density | 18 | 2018 | 209 | 1.960 |
Why?
|
| Estrogens | 16 | 2018 | 210 | 1.660 |
Why?
|
| Isoflavones | 19 | 2015 | 104 | 1.630 |
Why?
|
| Ovariectomy | 30 | 2018 | 204 | 1.560 |
Why?
|
| Animals | 102 | 2021 | 8579 | 1.520 |
Why?
|
| Estradiol | 11 | 2018 | 156 | 1.460 |
Why?
|
| Soybean Proteins | 17 | 2016 | 102 | 1.430 |
Why?
|
| African Americans | 20 | 2018 | 1435 | 1.360 |
Why?
|
| Carotid Artery Diseases | 7 | 2017 | 129 | 1.320 |
Why?
|
| Heart | 7 | 2018 | 191 | 1.240 |
Why?
|
| Postmenopause | 20 | 2019 | 461 | 1.240 |
Why?
|
| Female | 127 | 2021 | 21532 | 1.170 |
Why?
|
| Diet, Mediterranean | 5 | 2019 | 32 | 1.170 |
Why?
|
| Energy Intake | 3 | 2019 | 138 | 1.150 |
Why?
|
| Sertraline | 6 | 2017 | 27 | 1.040 |
Why?
|
| Iliac Artery | 9 | 2015 | 55 | 0.960 |
Why?
|
| Vitamin D | 4 | 2016 | 187 | 0.960 |
Why?
|
| Obesity | 12 | 2021 | 1246 | 0.950 |
Why?
|
| Monocytes | 5 | 2019 | 141 | 0.920 |
Why?
|
| Calcinosis | 10 | 2016 | 150 | 0.890 |
Why?
|
| Disease Models, Animal | 27 | 2018 | 1129 | 0.870 |
Why?
|
| Mammary Glands, Animal | 13 | 2016 | 69 | 0.870 |
Why?
|
| Adipose Tissue | 8 | 2018 | 366 | 0.850 |
Why?
|
| Myocardium | 5 | 2018 | 199 | 0.800 |
Why?
|
| Depression | 7 | 2017 | 458 | 0.770 |
Why?
|
| T-Lymphocytes | 6 | 2019 | 143 | 0.750 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 152 | 0.740 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 526 | 0.730 |
Why?
|
| Estrogens, Conjugated (USP) | 12 | 2013 | 159 | 0.720 |
Why?
|
| Extracellular Matrix | 5 | 2018 | 261 | 0.700 |
Why?
|
| Coronary Vessels | 11 | 2018 | 180 | 0.680 |
Why?
|
| Albuminuria | 5 | 2017 | 181 | 0.670 |
Why?
|
| Body Composition | 7 | 2019 | 415 | 0.670 |
Why?
|
| Gene Expression | 5 | 2018 | 363 | 0.660 |
Why?
|
| Fatty Liver | 2 | 2019 | 70 | 0.640 |
Why?
|
| Gamma Rays | 2 | 2019 | 25 | 0.630 |
Why?
|
| Soybeans | 8 | 2014 | 42 | 0.630 |
Why?
|
| Receptors, Estrogen | 8 | 2016 | 117 | 0.630 |
Why?
|
| Male | 60 | 2019 | 20740 | 0.620 |
Why?
|
| Calcium | 4 | 2018 | 343 | 0.620 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 37 | 0.620 |
Why?
|
| Aging | 10 | 2017 | 1010 | 0.590 |
Why?
|
| Adiponectin | 4 | 2013 | 111 | 0.580 |
Why?
|
| Homeostasis | 2 | 2018 | 137 | 0.580 |
Why?
|
| Adiposity | 4 | 2016 | 204 | 0.570 |
Why?
|
| Diastole | 1 | 2018 | 100 | 0.560 |
Why?
|
| Serotonin Uptake Inhibitors | 5 | 2017 | 42 | 0.560 |
Why?
|
| Middle Aged | 42 | 2019 | 12726 | 0.560 |
Why?
|
| Arteries | 4 | 2019 | 83 | 0.560 |
Why?
|
| Immunohistochemistry | 7 | 2020 | 600 | 0.550 |
Why?
|
| Coronary Artery Disease | 9 | 2018 | 441 | 0.550 |
Why?
|
| Humans | 72 | 2021 | 34562 | 0.540 |
Why?
|
| Estrogen Replacement Therapy | 10 | 2012 | 222 | 0.530 |
Why?
|
| Random Allocation | 16 | 2018 | 257 | 0.520 |
Why?
|
| Aged | 34 | 2019 | 11022 | 0.500 |
Why?
|
| Diet | 14 | 2021 | 418 | 0.480 |
Why?
|
| Cross-Sectional Studies | 10 | 2018 | 1607 | 0.480 |
Why?
|
| Haplorhini | 8 | 2019 | 75 | 0.470 |
Why?
|
| Time Factors | 11 | 2019 | 2353 | 0.460 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.460 |
Why?
|
| Cytokines | 2 | 2015 | 269 | 0.450 |
Why?
|
| Energy Metabolism | 4 | 2019 | 169 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2017 | 1079 | 0.450 |
Why?
|
| Diabetic Angiopathies | 3 | 2013 | 153 | 0.440 |
Why?
|
| Lipids | 6 | 2019 | 267 | 0.440 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 24 | 0.430 |
Why?
|
| Premenopause | 6 | 2019 | 55 | 0.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 111 | 0.420 |
Why?
|
| Norpregnenes | 6 | 2013 | 28 | 0.410 |
Why?
|
| Antigens, CD | 2 | 2015 | 106 | 0.410 |
Why?
|
| Muscle, Skeletal | 6 | 2019 | 575 | 0.390 |
Why?
|
| Alcohol Drinking | 4 | 2004 | 261 | 0.390 |
Why?
|
| Behavior, Animal | 5 | 2015 | 303 | 0.390 |
Why?
|
| Inflammation | 3 | 2013 | 557 | 0.390 |
Why?
|
| Diet, Atherogenic | 11 | 2018 | 76 | 0.390 |
Why?
|
| Chemokine CCL2 | 5 | 2018 | 52 | 0.380 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2014 | 302 | 0.370 |
Why?
|
| Cardiovascular Diseases | 8 | 2019 | 1209 | 0.350 |
Why?
|
| Body Mass Index | 9 | 2016 | 954 | 0.340 |
Why?
|
| Continental Population Groups | 1 | 2012 | 245 | 0.330 |
Why?
|
| Estrogen Receptor Modulators | 4 | 2013 | 30 | 0.320 |
Why?
|
| Selective Estrogen Receptor Modulators | 5 | 2013 | 38 | 0.310 |
Why?
|
| Alzheimer Disease | 3 | 2019 | 295 | 0.310 |
Why?
|
| Body Weight | 6 | 2016 | 343 | 0.310 |
Why?
|
| Adult | 20 | 2021 | 10030 | 0.310 |
Why?
|
| Estrogen Receptor alpha | 7 | 2018 | 54 | 0.310 |
Why?
|
| Arteriosclerosis | 3 | 2004 | 150 | 0.300 |
Why?
|
| Macaca mulatta | 4 | 2019 | 355 | 0.300 |
Why?
|
| Progesterone | 7 | 2014 | 112 | 0.300 |
Why?
|
| Apolipoproteins E | 5 | 2018 | 91 | 0.290 |
Why?
|
| Risk Factors | 18 | 2017 | 4137 | 0.290 |
Why?
|
| Peptide Fragments | 4 | 2019 | 430 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2007 | 43 | 0.290 |
Why?
|
| Medroxyprogesterone Acetate | 9 | 2008 | 115 | 0.280 |
Why?
|
| Breast | 5 | 2013 | 68 | 0.280 |
Why?
|
| Spine | 3 | 2018 | 47 | 0.280 |
Why?
|
| Mitochondria, Muscle | 2 | 2019 | 25 | 0.280 |
Why?
|
| Liver | 4 | 2009 | 513 | 0.270 |
Why?
|
| Women's Health | 1 | 2009 | 242 | 0.270 |
Why?
|
| Gene Expression Profiling | 7 | 2015 | 341 | 0.260 |
Why?
|
| Stress, Psychological | 5 | 2013 | 233 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2018 | 988 | 0.260 |
Why?
|
| Motor Activity | 6 | 2014 | 356 | 0.260 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2014 | 22 | 0.260 |
Why?
|
| Aggression | 3 | 2007 | 31 | 0.260 |
Why?
|
| Hippocampus | 3 | 2016 | 225 | 0.260 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 803 | 0.250 |
Why?
|
| Lipoproteins, HDL | 2 | 2014 | 257 | 0.250 |
Why?
|
| Cholesterol | 5 | 2018 | 273 | 0.250 |
Why?
|
| Ethanol | 3 | 2004 | 199 | 0.250 |
Why?
|
| Social Behavior | 5 | 2013 | 74 | 0.250 |
Why?
|
| Antidepressive Agents | 2 | 2017 | 78 | 0.250 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2019 | 83 | 0.240 |
Why?
|
| Primates | 4 | 2021 | 130 | 0.240 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2013 | 35 | 0.240 |
Why?
|
| Mammary Glands, Human | 2 | 2018 | 14 | 0.230 |
Why?
|
| Models, Animal | 6 | 2016 | 198 | 0.220 |
Why?
|
| Phosphates | 2 | 2015 | 28 | 0.220 |
Why?
|
| European Continental Ancestry Group | 9 | 2017 | 1176 | 0.220 |
Why?
|
| Breast Neoplasms | 7 | 2013 | 806 | 0.220 |
Why?
|
| Mortality | 2 | 2017 | 127 | 0.220 |
Why?
|
| Uterus | 5 | 2017 | 106 | 0.220 |
Why?
|
| Weight Loss | 2 | 2018 | 494 | 0.210 |
Why?
|
| Bone and Bones | 3 | 2018 | 99 | 0.210 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 8 | 0.200 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 13 | 0.200 |
Why?
|
| Organ Size | 5 | 2016 | 236 | 0.200 |
Why?
|
| Phytoestrogens | 4 | 2016 | 26 | 0.200 |
Why?
|
| Object Attachment | 1 | 2002 | 2 | 0.190 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2020 | 74 | 0.190 |
Why?
|
| Indoles | 2 | 2013 | 67 | 0.190 |
Why?
|
| Androgen Antagonists | 1 | 2002 | 20 | 0.190 |
Why?
|
| Macrophages | 3 | 2015 | 216 | 0.180 |
Why?
|
| Linkage Disequilibrium | 4 | 2016 | 189 | 0.180 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 2367 | 0.180 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 248 | 0.180 |
Why?
|
| Depressive Disorder | 2 | 2015 | 76 | 0.180 |
Why?
|
| Ovary | 3 | 2017 | 69 | 0.170 |
Why?
|
| Absorptiometry, Photon | 6 | 2018 | 144 | 0.170 |
Why?
|
| Hormone Replacement Therapy | 3 | 2017 | 96 | 0.170 |
Why?
|
| Intra-Abdominal Fat | 2 | 2013 | 67 | 0.170 |
Why?
|
| Kidney Diseases | 2 | 2014 | 249 | 0.170 |
Why?
|
| Foam Cells | 2 | 2010 | 14 | 0.160 |
Why?
|
| Cell Proliferation | 7 | 2013 | 633 | 0.160 |
Why?
|
| Phenotype | 4 | 2016 | 657 | 0.160 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 306 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 3 | 2017 | 315 | 0.160 |
Why?
|
| Progestins | 2 | 2013 | 27 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 165 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 19 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2020 | 25 | 0.160 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 4157 | 0.160 |
Why?
|
| Keratosis | 1 | 2020 | 23 | 0.160 |
Why?
|
| Contraceptives, Oral | 3 | 2008 | 27 | 0.160 |
Why?
|
| Mice | 11 | 2018 | 2720 | 0.160 |
Why?
|
| Genome-Wide Association Study | 3 | 2017 | 555 | 0.150 |
Why?
|
| Helicobacter pylori | 1 | 2019 | 8 | 0.150 |
Why?
|
| Helicobacter Infections | 1 | 2019 | 9 | 0.150 |
Why?
|
| Cell Polarity | 1 | 2019 | 17 | 0.150 |
Why?
|
| Health Status | 1 | 2002 | 411 | 0.150 |
Why?
|
| Peptides | 2 | 2018 | 143 | 0.150 |
Why?
|
| Hematopoietic System | 1 | 2019 | 3 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 922 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 849 | 0.150 |
Why?
|
| Kidney Function Tests | 2 | 2017 | 107 | 0.150 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2019 | 38 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 112 | 0.150 |
Why?
|
| Immunity | 1 | 2019 | 22 | 0.150 |
Why?
|
| Disease Progression | 3 | 2016 | 634 | 0.150 |
Why?
|
| Aromatase | 1 | 2018 | 12 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 149 | 0.140 |
Why?
|
| Sexual Maturation | 2 | 2016 | 28 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2018 | 104 | 0.140 |
Why?
|
| Endometrium | 5 | 2013 | 183 | 0.140 |
Why?
|
| Elastin | 2 | 2016 | 17 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2013 | 771 | 0.140 |
Why?
|
| RNA | 2 | 2013 | 100 | 0.140 |
Why?
|
| Psoas Muscles | 1 | 2018 | 21 | 0.140 |
Why?
|
| Granulosa Cells | 1 | 2017 | 11 | 0.140 |
Why?
|
| Insulin | 2 | 2019 | 394 | 0.130 |
Why?
|
| Radius | 1 | 2017 | 27 | 0.130 |
Why?
|
| Macaca | 2 | 2018 | 30 | 0.130 |
Why?
|
| Sex Factors | 3 | 2017 | 708 | 0.130 |
Why?
|
| Diabetes Complications | 3 | 2013 | 189 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Dietary Proteins | 3 | 2014 | 67 | 0.130 |
Why?
|
| Collagen Type I | 3 | 2013 | 48 | 0.130 |
Why?
|
| Carotid Arteries | 2 | 2015 | 116 | 0.130 |
Why?
|
| Calpain | 1 | 2017 | 14 | 0.130 |
Why?
|
| Lipolysis | 1 | 2017 | 18 | 0.130 |
Why?
|
| Carotid Artery, Common | 1 | 2017 | 49 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2017 | 86 | 0.130 |
Why?
|
| Collagen | 2 | 2016 | 240 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Lipoproteins | 4 | 2006 | 99 | 0.130 |
Why?
|
| Receptor, EphB2 | 1 | 2016 | 4 | 0.120 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 19 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2016 | 61 | 0.120 |
Why?
|
| Ethnic Groups | 3 | 2014 | 483 | 0.120 |
Why?
|
| Genotype | 6 | 2017 | 744 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2016 | 21 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2016 | 45 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2016 | 13 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 12 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 22 | 0.120 |
Why?
|
| Frozen Sections | 1 | 2016 | 19 | 0.120 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 52 | 0.120 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 47 | 0.120 |
Why?
|
| Aortic Diseases | 1 | 2016 | 67 | 0.120 |
Why?
|
| DNA Methylation | 2 | 2015 | 147 | 0.120 |
Why?
|
| Sex Characteristics | 3 | 2013 | 182 | 0.120 |
Why?
|
| Dominance-Subordination | 3 | 2005 | 17 | 0.120 |
Why?
|
| Fatty Acids | 2 | 2019 | 108 | 0.120 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2015 | 2 | 0.110 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 194 | 0.110 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 498 | 0.110 |
Why?
|
| Menisci, Tibial | 1 | 2015 | 24 | 0.110 |
Why?
|
| Menopause | 2 | 2013 | 111 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 628 | 0.110 |
Why?
|
| Myosin Heavy Chains | 2 | 2012 | 89 | 0.110 |
Why?
|
| Substance P | 1 | 2014 | 23 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2012 | 115 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2016 | 485 | 0.110 |
Why?
|
| Rotator Cuff | 1 | 2015 | 77 | 0.110 |
Why?
|
| Upper Extremity | 1 | 2015 | 69 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 96 | 0.110 |
Why?
|
| Exercise | 2 | 2018 | 701 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 178 | 0.110 |
Why?
|
| Radiography | 5 | 2015 | 397 | 0.110 |
Why?
|
| Wnt1 Protein | 1 | 2014 | 3 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2014 | 122 | 0.100 |
Why?
|
| Pathology, Clinical | 1 | 2014 | 16 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2014 | 5 | 0.100 |
Why?
|
| Knee Joint | 1 | 2015 | 151 | 0.100 |
Why?
|
| Brain | 2 | 2018 | 1032 | 0.100 |
Why?
|
| Biogenic Monoamines | 1 | 2013 | 10 | 0.100 |
Why?
|
| Neuroglia | 1 | 2014 | 32 | 0.100 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2014 | 41 | 0.100 |
Why?
|
| Plant Preparations | 2 | 2004 | 29 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2013 | 132 | 0.100 |
Why?
|
| Hierarchy, Social | 2 | 2013 | 26 | 0.100 |
Why?
|
| Mammography | 1 | 2013 | 43 | 0.100 |
Why?
|
| Puberty | 1 | 2013 | 8 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2015 | 198 | 0.100 |
Why?
|
| African Continental Ancestry Group | 4 | 2010 | 367 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2013 | 13 | 0.100 |
Why?
|
| Synapses | 1 | 2014 | 89 | 0.100 |
Why?
|
| Endometrial Hyperplasia | 2 | 2013 | 14 | 0.100 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 23 | 0.100 |
Why?
|
| Calcifediol | 1 | 2012 | 10 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 439 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 228 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.090 |
Why?
|
| Apolipoproteins | 1 | 2014 | 201 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2015 | 390 | 0.090 |
Why?
|
| Mobility Limitation | 1 | 2014 | 222 | 0.090 |
Why?
|
| Blood Glucose | 4 | 2019 | 529 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2013 | 80 | 0.090 |
Why?
|
| Pterocarpans | 1 | 2011 | 5 | 0.090 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 35 | 0.090 |
Why?
|
| Apoptosis | 3 | 2013 | 400 | 0.090 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 33 | 0.090 |
Why?
|
| bcl-Associated Death Protein | 2 | 2013 | 11 | 0.090 |
Why?
|
| Housing, Animal | 1 | 2011 | 24 | 0.090 |
Why?
|
| Lumbar Vertebrae | 4 | 2017 | 114 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 193 | 0.090 |
Why?
|
| Cross-Over Studies | 4 | 2019 | 100 | 0.090 |
Why?
|
| Epinephrine | 2 | 2013 | 45 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2016 | 657 | 0.090 |
Why?
|
| Collagen Type III | 1 | 2011 | 9 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2015 | 901 | 0.090 |
Why?
|
| Gait | 1 | 2011 | 134 | 0.080 |
Why?
|
| Thoracic Vertebrae | 2 | 2017 | 45 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2017 | 508 | 0.080 |
Why?
|
| Shoulder Joint | 1 | 2013 | 141 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2010 | 4 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 19 | 0.080 |
Why?
|
| Cathepsin K | 1 | 2010 | 2 | 0.080 |
Why?
|
| Pericardium | 1 | 2010 | 55 | 0.080 |
Why?
|
| Prevalence | 3 | 2019 | 1034 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2010 | 72 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 126 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2015 | 545 | 0.080 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2009 | 12 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Carotid Stenosis | 1 | 2010 | 61 | 0.080 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 8 | 0.080 |
Why?
|
| Drug Therapy, Combination | 4 | 2002 | 318 | 0.080 |
Why?
|
| Estrogen Receptor beta | 2 | 2007 | 15 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2009 | 60 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2010 | 254 | 0.070 |
Why?
|
| Tamoxifen | 2 | 2007 | 66 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 281 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2017 | 1910 | 0.070 |
Why?
|
| Insulin Resistance | 3 | 2019 | 488 | 0.070 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2008 | 4 | 0.070 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 6 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 842 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2008 | 13 | 0.070 |
Why?
|
| Solubility | 2 | 2007 | 43 | 0.070 |
Why?
|
| CpG Islands | 3 | 2015 | 45 | 0.070 |
Why?
|
| North Carolina | 1 | 2013 | 1613 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 175 | 0.070 |
Why?
|
| Genistein | 2 | 2008 | 17 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 21 | 0.070 |
Why?
|
| Demography | 3 | 2016 | 112 | 0.070 |
Why?
|
| Monkey Diseases | 1 | 2008 | 28 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Vasculitis | 1 | 2007 | 26 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 11 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 28 | 0.070 |
Why?
|
| Biopsy | 3 | 2016 | 273 | 0.070 |
Why?
|
| Adrenergic Agonists | 1 | 2007 | 8 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 585 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 20 | 0.060 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 10 | 0.060 |
Why?
|
| Heart Failure | 1 | 2014 | 780 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2006 | 20 | 0.060 |
Why?
|
| Risk | 2 | 2019 | 325 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 1606 | 0.060 |
Why?
|
| Arousal | 2 | 2005 | 20 | 0.060 |
Why?
|
| Vagina | 1 | 2007 | 61 | 0.060 |
Why?
|
| Vegetables | 1 | 2006 | 41 | 0.060 |
Why?
|
| Epithelial Cells | 3 | 2013 | 148 | 0.060 |
Why?
|
| Progesterone Congeners | 2 | 2002 | 22 | 0.060 |
Why?
|
| Placebos | 3 | 2014 | 69 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 2 | 2016 | 30 | 0.060 |
Why?
|
| Administration, Oral | 4 | 2007 | 213 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 278 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 44 | 0.060 |
Why?
|
| Age Factors | 3 | 2015 | 1262 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2006 | 239 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 36 | 0.060 |
Why?
|
| Serum | 1 | 2004 | 18 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 142 | 0.050 |
Why?
|
| Adrenal Cortex | 1 | 2004 | 5 | 0.050 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2004 | 12 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 97 | 0.050 |
Why?
|
| Creatinine | 2 | 2017 | 206 | 0.050 |
Why?
|
| Genitalia, Female | 1 | 2004 | 10 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 808 | 0.050 |
Why?
|
| Genitalia, Male | 1 | 2004 | 5 | 0.050 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2014 | 19 | 0.050 |
Why?
|
| Receptors, Steroid | 3 | 2011 | 12 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 216 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2018 | 486 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 189 | 0.050 |
Why?
|
| Densitometry | 1 | 2003 | 8 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 804 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2014 | 45 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 596 | 0.050 |
Why?
|
| Esterification | 1 | 2002 | 4 | 0.050 |
Why?
|
| E-Selectin | 1 | 2002 | 21 | 0.050 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 14 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2002 | 23 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2002 | 10 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 2008 | 61 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 44 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2002 | 46 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 18 | 0.050 |
Why?
|
| Telomerase | 1 | 2002 | 22 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 755 | 0.040 |
Why?
|
| Muscular Atrophy | 2 | 2012 | 77 | 0.040 |
Why?
|
| Cricetinae | 2 | 2014 | 52 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2018 | 510 | 0.040 |
Why?
|
| United States | 3 | 2017 | 4278 | 0.040 |
Why?
|
| Lactalbumin | 2 | 2014 | 15 | 0.040 |
Why?
|
| Caseins | 2 | 2014 | 21 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2002 | 67 | 0.040 |
Why?
|
| Bacteroides | 1 | 2021 | 8 | 0.040 |
Why?
|
| Prevotella | 1 | 2021 | 8 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 114 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2021 | 13 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 43 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 22 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 33 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1393 | 0.040 |
Why?
|
| Rats | 2 | 2014 | 1946 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2020 | 73 | 0.040 |
Why?
|
| Ketone Bodies | 1 | 2019 | 8 | 0.040 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 2 | 2013 | 24 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3623 | 0.040 |
Why?
|
| Lipoproteins, LDL | 2 | 2010 | 101 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2013 | 32 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 465 | 0.040 |
Why?
|
| Triglycerides | 2 | 2011 | 249 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 7 | 0.040 |
Why?
|
| Heart Rate | 2 | 2014 | 372 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 94 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2019 | 17 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2019 | 30 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2019 | 33 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 104 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 50 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2018 | 14 | 0.040 |
Why?
|
| Autopsy | 1 | 2018 | 38 | 0.040 |
Why?
|
| Microscopy | 1 | 2018 | 28 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2011 | 42 | 0.030 |
Why?
|
| Ki-67 Antigen | 2 | 2012 | 34 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 42 | 0.030 |
Why?
|
| Strontium | 1 | 2017 | 5 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2017 | 10 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 781 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2014 | 2463 | 0.030 |
Why?
|
| Theca Cells | 1 | 2017 | 9 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 113 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 26 | 0.030 |
Why?
|
| Femur Neck | 1 | 2017 | 23 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2018 | 75 | 0.030 |
Why?
|
| Memory | 1 | 2019 | 216 | 0.030 |
Why?
|
| Administration, Intravaginal | 2 | 2007 | 9 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 185 | 0.030 |
Why?
|
| Multigene Family | 2 | 2007 | 54 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2017 | 153 | 0.030 |
Why?
|
| Alginates | 1 | 2017 | 52 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2017 | 65 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2018 | 168 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 30 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 74 | 0.030 |
Why?
|
| Hot Flashes | 1 | 2017 | 51 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 265 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 480 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 145 | 0.030 |
Why?
|
| Models, Biological | 2 | 2011 | 432 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2016 | 22 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2016 | 44 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 94 | 0.030 |
Why?
|
| Lod Score | 1 | 2016 | 73 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 142 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 167 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 204 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 823 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 11 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 29 | 0.030 |
Why?
|
| Menopause, Premature | 1 | 2015 | 11 | 0.030 |
Why?
|
| Animal Feed | 2 | 2005 | 24 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 44 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2015 | 109 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2014 | 8 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 56 | 0.030 |
Why?
|
| Thyroxine | 1 | 2014 | 18 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 116 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 78 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2014 | 17 | 0.030 |
Why?
|
| Lanthanum | 1 | 2014 | 3 | 0.030 |
Why?
|
| Phosphorus, Dietary | 1 | 2014 | 3 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 22 | 0.030 |
Why?
|
| Somatomedins | 1 | 2014 | 5 | 0.030 |
Why?
|
| Glucuronidase | 1 | 2014 | 12 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 26 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 43 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 130 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2014 | 44 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 194 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 515 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 45 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 231 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cause of Death | 1 | 2014 | 245 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 27 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 50 | 0.020 |
Why?
|
| Receptors, Adiponectin | 1 | 2013 | 3 | 0.020 |
Why?
|
| Muramidase | 1 | 2013 | 8 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 56 | 0.020 |
Why?
|
| Tunica Media | 1 | 2013 | 41 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 130 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 3 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2013 | 81 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2013 | 6 | 0.020 |
Why?
|
| Propanolamines | 1 | 2013 | 12 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 71 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 27 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2013 | 35 | 0.020 |
Why?
|
| Leptin | 1 | 2013 | 75 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2013 | 25 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 40 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 29 | 0.020 |
Why?
|
| Astrocytes | 1 | 2013 | 64 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 202 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 67 | 0.020 |
Why?
|
| Isotonic Contraction | 1 | 2012 | 8 | 0.020 |
Why?
|
| Myofibrils | 1 | 2012 | 8 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2013 | 103 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 123 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 128 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 110 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 203 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 597 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 63 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 101 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 923 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 296 | 0.020 |
Why?
|
| Cercopithecidae | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 146 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 209 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2011 | 25 | 0.020 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Claudins | 1 | 2011 | 8 | 0.020 |
Why?
|
| Lactation | 1 | 2011 | 19 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 27 | 0.020 |
Why?
|
| Aorta | 2 | 2002 | 139 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 30 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 576 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 106 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 34 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 91 | 0.020 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 15 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 115 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 20 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 926 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 176 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 928 | 0.020 |
Why?
|
| Phosphorus | 1 | 2010 | 11 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 111 | 0.020 |
Why?
|
| Collagenases | 1 | 2010 | 9 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 142 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 11 | 0.020 |
Why?
|
| Epitopes | 1 | 2010 | 28 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2010 | 8 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2010 | 5 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 34 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2010 | 51 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3825 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 73 | 0.020 |
Why?
|
| Anthropometry | 1 | 2009 | 89 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 219 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 52 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 21 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 36 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2008 | 12 | 0.020 |
Why?
|
| Social Dominance | 1 | 2008 | 24 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 35 | 0.020 |
Why?
|
| Luteal Phase | 1 | 2008 | 30 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 1069 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2008 | 50 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 107 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 889 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2007 | 16 | 0.020 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 476 | 0.020 |
Why?
|
| Europe | 1 | 2007 | 86 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 44 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 15 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 148 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 264 | 0.020 |
Why?
|
| Haplotypes | 1 | 2006 | 221 | 0.020 |
Why?
|
| Steryl-Sulfatase | 1 | 2006 | 3 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2006 | 10 | 0.020 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 3 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 2005 | 11 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 69 | 0.010 |
Why?
|
| Estrus | 1 | 2005 | 6 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2005 | 23 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 163 | 0.010 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2004 | 14 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 99 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 20 | 0.010 |
Why?
|
| Androgens | 1 | 2004 | 32 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 2004 | 17 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 57 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2004 | 72 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 21 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 42 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 2002 | 42 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 56 | 0.010 |
Why?
|
| Ilium | 1 | 2002 | 16 | 0.010 |
Why?
|
| Horses | 1 | 2002 | 18 | 0.010 |
Why?
|
| Life Style | 1 | 2005 | 418 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 168 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 48 | 0.010 |
Why?
|
| Femur | 1 | 2002 | 82 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 69 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 110 | 0.010 |
Why?
|
| Dobutamine | 1 | 2002 | 71 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 114 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 544 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 614 | 0.010 |
Why?
|